92 related articles for article (PubMed ID: 21645038)
1. CD117 (c-KIT) staining in desmoplastic melanoma.
North J
J Cutan Pathol; 2011 Sep; 38(9):753-5. PubMed ID: 21645038
[No Abstract] [Full Text] [Related]
2. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
Isabel Zhu Y; Fitzpatrick JE
J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone KT; van Belle P; Elenitsas R; Elder DE
Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
[TBL] [Abstract][Full Text] [Related]
4. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
5. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.
Guerriere-Kovach PM; Hunt EL; Patterson JW; Glembocki DJ; English JC; Wick MR
Am J Clin Pathol; 2004 Jul; 122(1):70-7. PubMed ID: 15272532
[TBL] [Abstract][Full Text] [Related]
6. Expression of the ets-1 proto-oncogene in melanocytic lesions.
Keehn CA; Smoller BR; Morgan MB
Mod Pathol; 2003 Aug; 16(8):772-7. PubMed ID: 12920221
[TBL] [Abstract][Full Text] [Related]
7. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Nazarian RM; Prieto VG; Elder DE; Duncan LM
J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
[TBL] [Abstract][Full Text] [Related]
8. Somatic activation of KIT in distinct subtypes of melanoma.
Curtin JA; Busam K; Pinkel D; Bastian BC
J Clin Oncol; 2006 Sep; 24(26):4340-6. PubMed ID: 16908931
[TBL] [Abstract][Full Text] [Related]
9. CD117 is not a useful marker for diagnosing atypical fibroxanthoma.
Barr KL; Russo JJ; Vincek V
Am J Dermatopathol; 2010 Jul; 32(5):528. PubMed ID: 20526172
[No Abstract] [Full Text] [Related]
10. Immunohistochemistry of a choroidal melanoma: nestin, CD34 and CD117÷c-kit labeling.
Vrapciu AD; Rusu MC; Voinea LM
Rom J Morphol Embryol; 2014; 55(2):437-42. PubMed ID: 24969998
[TBL] [Abstract][Full Text] [Related]
11. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
Giehl KA; Nägele U; Volkenandt M; Berking C
J Cutan Pathol; 2007 Jan; 34(1):7-14. PubMed ID: 17214848
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
Tron VA; Krajewski S; Klein-Parker H; Li G; Ho VC; Reed JC
Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
[TBL] [Abstract][Full Text] [Related]
13. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
14. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
Anurova OA; Likhvantseva VG; Vereshchagina MV
Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
[TBL] [Abstract][Full Text] [Related]
15. c-Kit (CD117) expression in classic Kaposi's sarcoma.
Kandemir NO; Gun BD; Bahadir B; Yurdakan G; Ozdemir N; Karadayi N; Ozdamar SO
Clin Exp Dermatol; 2010 Jul; 35(5):525-30. PubMed ID: 19874361
[TBL] [Abstract][Full Text] [Related]
16. A case of cutaneous leiomyosarcoma with overexpression of KIT: do CD117 (KIT)-positive primary gastrointestinal stromal tumours of the skin exist?
Horie M; Hatamochi A; Yamazaki S; Izumi M; Mukai K
Br J Dermatol; 2006 May; 154(5):1013-6. PubMed ID: 16634920
[No Abstract] [Full Text] [Related]
17. CD117 immunoreactivity in atypical fibroxanthoma.
Mathew RA; Schlauder SM; Calder KB; Morgan MB
Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome.
Gonzalez RS; Carlson G; Page AJ; Cohen C
Am J Clin Pathol; 2011 Jul; 136(1):74-80. PubMed ID: 21685034
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma: an immunohistochemical study and analysis of prognostic value.
Oba J; Nakahara T; Abe T; Hagihara A; Moroi Y; Furue M
J Dermatol Sci; 2011 May; 62(2):116-23. PubMed ID: 21454057
[TBL] [Abstract][Full Text] [Related]
20. Malignant blue nevus with lymph node metastases.
Zyrek-Betts J; Micale M; Lineen A; Chaudhuri PK; Keil S; Xue J; Thomas JE
J Cutan Pathol; 2008 Jul; 35(7):651-7. PubMed ID: 17976211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
